←Back to Expert Scholars
Translational Medicine / 转化医学Cancer Antisense Oligonucleotides
Stanley Crooke
MD, PhD
🏢Ionis Pharmaceuticals🌐USA
Founder and Chair, n-Lorem Foundation; Founder, Ionis Pharmaceuticals
100
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Stanley Crooke founded Ionis Pharmaceuticals and pioneered the antisense oligonucleotide therapeutic field. His work established the chemistry, pharmacology, and clinical translation of ASOs for cancer and genetic disease. He founded the n-Lorem Foundation for individualized ASO therapy.
Share:
🧪Research Fields 研究领域
antisense oligonucleotides
RNase H mechanism
ASO chemistry
cancer ASO therapy
phosphorothioate backbone
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Stanley Crooke 的研究动态
Follow Stanley Crooke's research updates
留下邮箱，当我们发布与 Stanley Crooke（Ionis Pharmaceuticals）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment